Our commitment, embodied in our “Beyond Boundaries” promise, is to create new solutions for industries, transcending limitations of size, weight, power and dose.
Micro-X has achieved the extraordinary, moving beyond the century-old boundaries of traditional thermionic X-ray technology. Our breakthrough with instantaneous X-ray driven by electronically controlled carbon nanotube emitters moves X-ray beyond heated filaments encased in oil, taking X-ray into the future. With this innovation, we are not just advancing technology, we are redefining what is possible.
In 2011, a group of engineers and scientists found a way to create a simple, scalable and repeatable X-ray tube that uses carbon nanotube technology. This Nano Electronic X-ray (NEX) Technology forms the core of a common platform for all our products, delivering quality digital imaging through proprietary high-voltage X-ray tubes and high-voltage generators.
With a vertically integrated design and production facility in Adelaide, Australia and a strong technical and commercial team based in Seattle, USA, we are focused on delivering exceptional innovative products that change lives for the better.
In our hub in Tonsley, South Australia, we manufacture X-ray tubes, high voltage generators and high voltage switches for use in our products in the health and security industries. Through our customer-led, proven and collaborative processes, we can deliver scalable and innovative technology. It’s this technology that allows us to create new products designed to better lives, globally.
In 2021, we opened our US base in Seattle, Washington, driving our global expansion into key markets. Our Seattle facility is a strategic initiative to serve business opportunities in North America, including a continued focus on delivering solutions for the US Government.
Through our tenacity and commitment to being global leaders, Micro-X is creating the future of X-ray and CT imaging.
Our Nano Electronic X-ray tube is simple and scalable, with a more stable and longer life than ever before. It challenges every existing barrier for traditional X-ray imaging and creates new opportunities for industries across the world.
We are tackling new frontiers in science, driven by the global challenge of promoting good health and creating a safer, more sustainable future.
Our products are designed to address the problems of today and drive positive change for a better tomorrow.
We challenge the status quo and push boundaries through curiosity to drive radical innovation and continuous improvement.
We achieve everything as one team. People are the heart of Micro-X, and our collective talents drive us forward to solve problems together.
No matter the challenge, we push forward to find a solution. We do the right thing, own our mistakes, learn, and move forward smarter and stronger.
Kingsley Hall was appointed Chief Executive Officer in April 2023. Kingsley joined Micro-X in February 2020 as CFO and Company Secretary and has been a member of the leadership team since that time.
Kingsley has over 25 years of experience in both operational and finance leadership roles with a diverse background across both private and public companies, private equity, technology and media.
Prior to joining Micro-X, Kingsley held a number of senior operational roles as either Director of Operations or Chief Operating Officer with overall responsibility for sales, operations and profit and loss outcomes.
Kingsley holds a Bachelor of Economics and is a member of the Institute of Chartered Accountants.
As Chief Operating Officer at Micro-X, Anthony brings extensive experience in high technology product development. In the UK he worked on engineering development and project management of cutting edge telecommunication systems for Lucent Technologies, solid state NAS systems for start-up BlueArc, and scientific vacuum products for BOC Edwards.
On moving to Australia in 2006, as a senior consultant at Invetech, he led engineering teams delivering products in highly regulated sectors for clients such as Coca-Cola, Phillips, BlueScope Steel, Magotteaux and MDS Sciex. More recently he worked as a program director at Hydrix on military and medical devices, growing project and mechanical engineering capability, before moving to South Australia to establish a regional division of Hydrix as General Manager.
Brian is the Chief Scientist of Micro-X and the CEO of Micro-X Inc, the US subsidiary.
Brian has a Ph.D. in biomedical engineering from UNC and NC State University and has published in multiple peer-reviewed scientific journals, focused on X-ray CT using carbon nanotube X-ray technology. Brian has worked with carbon nanotube X-ray technology from the early research at UNC, leading the early development at XinRay Systems, and then assisting in the transition to full commercialization of the technology at Micro-X in partnership with Flinders University and the University of Melbourne in Australia.
Throughout the technology development, Brian has established himself as a research member of the US DHS-funded ALERT community, a scientific, corporate, and government community working to advance Airport security technology. Brian has led the engagement with DHS and TSA to utilize the carbon nanotube X-ray technology to transform airport security screening.
Scott is a former US Navy Special Operations officer who retired after 28 years of service. He is the former Director of Sales for Two Markets at ADS, Inc., earning over $420 million USD in revenue. He also served as the VP of Sales for Transcend Robotics bringing about a 130% increase over the prior year in only 9-months.
He has an MBA from The College of William and Mary and a Masters in Human Resources Management from Cornell University. He currently resides in Virginia, USA.
David is a highly experienced and respected business leader with senior leadership, engineering and public markets expertise gained in multi-national, domestic and Commonwealth companies. David was Managing Director & Chief Executive Officer of Australian Naval Infrastructure, a Government Business Enterprise responsible for the delivery of naval infrastructure required to support the Commonwealth’s continuous shipbuilding programme. including the $535m Osborne South Shipyard. David was previously Managing Director & Chief Executive Officer of Santos from March 2008 through until his retirement in December 2015.
David Knox is currently Chair of Snowy Hydro Limited and The Australian Centre for Social Innovation (TACSI). He is also a board member of Commonwealth Scientific and Industrial Research Organisation (CSIRO), Redflow Limited (ASX – RFX), Migration Council of Australia, Adelaide Festival (AF) and the Royal Institution of Australia (RiAUS). David Knox is originally from Edinburgh, Scotland and has a BSc (Hons) in Mechanical Engineering (Edinburgh) and an MBA (Strathclyde). He is a Fellow of the Australian Institute of Mechanical Engineering and the Australian Academy of Technological Sciences and Engineering.
Jim is Chief Executive of Nova Systems and has more than 30 years of experience in international defence and aerospace sectors and has lived and worked in the UK, the USA, Korea, Singapore, Hong Kong and Australia. Prior to this appointment Jim was Chief Executive of South Australia’s Department of Premier and Cabinet. Jim joined BAE Systems in 1996 and his last executive appointment with the Group was as Chief Executive Officer of their A$5 billion annual turnover business operations in Saudi Arabia. Prior to this he was Chief Executive Officer of BAE Systems Australia for 10 years. Based in Adelaide, he drove a major expansion program as the Group grew to become Australia’s largest defence business.
Prior to his time at BAE Systems Jim worked for 18 years at aerospace Group Bombardier Shorts in legal, commercial and marketing positions, making a major contribution to that Group’s growth into the USA. In 2014, Jim was appointed by the Australian Federal Government to the team to conduct the First Principles Review of the Australian Department of Defence. The Team’s ‘One Defence’ recommendations included transformational changes to structure, governance arrangements, accountabilities, processes and systems of Defence. Jim was also Chair of the Australian Nuclear Science & Technology Organisation which is a centre-of-excellence in Australia for radiation safety and nuclear medicine research.
Patrick has over 35 years’ business experience in Australia, the UK, Europe, Asia and the US including as a senior managing director with Macquarie Group where he led teams in corporate finance (Melbourne 1996-2005) and private equity (London 2005-2009). In this latter role Patrick was responsible for Macquarie’s controlling stakes in, and chaired, large unlisted groups European Directories and National Grid Wireless.
On leaving Macquarie, Patrick has focused on working with early stage growth companies, mostly in the technology sector. He has advised, invested in and been an active director or chairman of a number of such companies, assisting them with issues such as capital structure, funding options, and growth strategies. He was Chairman of the Paywise Group following a management buyout in 2019 through to a successful sale process in 2023. He is currently a director of The Water & Carbon Group and O’Brien Capital and related entities.
Prior to Macquarie, Patrick was a strategy consultant with McKinsey & Company and a lawyer with Minter Ellison.
Ilona has over 25 years’ experience as a senior executive in healthcare, agriculture and emerging technologies focusing on innovation and growth. Ilona is General Counsel for Nuix Limited and prior to this role had held multiple executive roles with private and public companies, including ASX-listed companies and high-growth start-ups, leading business transformation initiatives, managing multiple stakeholders, influencing industry bodies, as well as navigating complex litigation and regulatory disputes.
Prior to commencing her current role at Nuix, Ilona was General Counsel and Head of Legal & Compliance of the Boehringer Ingelheim Group for the Australian and New Zealand division. She has previously held senior legal and general counsel roles at ResMed Limited, Ruralco Holdings Limited, Medtronic and 3M Australia.
Andrew works at Varex as Senior Vice President of Sales and Marketing, Medical. He has significant business expertise in the field of medical imaging devices, with extensive experience working in global roles with a focus on sales, marketing, and business operations. He is responsible for driving and growing Varex’s $674m medical business through sales, marketing and operations.
Over his career, Andrew has been responsible for building brand, market share and bottom-line gains through cost saving and efficiency improvements. Originally from Australia, Andrew has worked overseas and in global senior roles for more than 30 years. He has held senior global management roles at Phillips, Carestream and Siemens, after working in senior roles in Australia that included building brands across the Asia-Pacific region, the United States and Europe.
Alexander has been working in the field of process and product development and related research and development for 50 years. He was a founding director of Invetech and was part of the management team that led Invetech to a public listing (as Vision Systems) and then to its acquisition by Danaher Corp for $800M. He currently works in the area of technology commercialisation, advising universities, mentoring start-ups and sitting on the Boards of early stage companies.
Alexander is an engineer, with an Honours degree from Cambridge University. He is a Fellow of the Academy of Technology and Engineering, a Fellow of the Institute of Engineers Australia and a Governor of the Warren Centre for Advanced Engineering. He was awarded an Honorary Doctorate in Engineering from Swinburne University and made a Member of The Order of Australia for services to engineering. He is a Member of the Australian Institute of Company Directors.
$1.5M Varex milestone achieved. Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cathode X-ray technology for health and security markets globally, is pleased to announce the achievement of the fifth and final milestone under the Varex licence agreement.
It’s a pleasure to deliver to you our second newsletter with updates and insights into our achievements across the business.
Read about the design of Micro-X's Head CT from Dr Nyein Chan Aung, Monash University Design Health Collab.
